New therapies give scientists new hope for being able to detect and treat symptoms of Alzheimer's disease during the early stages of its development.
Finding Could Have Implications for Alzheimer's Disease.
Training the body's immune system to fight back against Alzheimer's disease may still offer a promising option for slowing or even preventing the tragic brain disorder.
People with very mild Alzheimer's disease are still competent to make decisions about their treatment, while those with moderate Alzheimer's may not.
Physical activity appears to inhibit Alzheimer's like brain changes in mice, slowing the development of a key feature of the disease.
Researchers have identified a single gene that influences the age at which individuals first show symptoms of Alzheimer's and Parkinson's diseases.
The genes that influence the risk of developing Alzheimer's disease may vary over the course of an individual's lifetime.
Alzheimer's disease is the most common form of dementia among Americans over the age of 80. Donepezil is one of four drugs currently approved by the Food and Drug Administration for the treatment of mild to moderate Alzheimer's disease.
Mutations that raise the risk of Alzheimer's have been found in four genes. Researchers expect that several additional genes that affect the risk of developing Alzheimer's may be found.
A heart-healthy lifestyle, including diet and exercise, may help to delay the onset of Alzheimer's disease. A number of drugs also seem to affect the brain changes that may lead to Alzheimer's disease.
The impact of Alzheimer's disease on Hispanic communities in the U.S. is serious and getting worse. Not only do Hispanics have a higher rate of Alzheimer's than non Latino whites, but onset occurs at an earlier age.